258 related articles for article (PubMed ID: 34714605)
1. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis.
Kharoubi M; Bézard M; Galat A; Le Bras F; Poullot E; Molinier-Frenkel V; Fanen P; Funalot B; Moktefi A; Lefaucheur JP; Abulizi M; Deux JF; Lemonnier F; Guendouz S; Chalard C; Zaroui A; Audard V; Bequignon E; Bodez D; Itti E; Hittinger L; Audureau E; Teiger E; Oghina S; Damy T
ESC Heart Fail; 2021 Dec; 8(6):5501-5512. PubMed ID: 34714605
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
Annabi MS; Carter-Storch R; Zaroui A; Galat A; Oghina S; Kharoubi M; Bezard M; Derumeaux G; Fanen P; Lemonnier F; Poullot E; Itti E; Gallet R; Teiger E; Pibarot P; Damy T; Clavel MA
J Am Heart Assoc; 2024 Jun; ():e034723. PubMed ID: 38904242
[TBL] [Abstract][Full Text] [Related]
3. Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.
Bonnefous L; Kharoubi M; Bézard M; Oghina S; Le Bras F; Poullot E; Molinier-Frenkel V; Fanen P; Deux JF; Audard V; Itti E; Damy T; Audureau E
J Am Coll Cardiol; 2021 Nov; 78(22):2177-2192. PubMed ID: 34823661
[TBL] [Abstract][Full Text] [Related]
4. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study.
Bartier S; Bodez D; Kharoubi M; Canouï-Poitrine F; Chatelin V; Henrion C; Coste A; Damy T; Béquignon E
Amyloid; 2019 Dec; 26(4):216-224. PubMed ID: 31364411
[No Abstract] [Full Text] [Related]
5. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and determinants of iron deficiency in cardiac amyloidosis.
Jobbé-Duval A; Bézard M; Moutereau S; Kharoubi M; Oghina S; Zaroui A; Galat A; Chalard C; Hugon-Vallet E; Lemonnier F; Eyharts D; Poulot E; Fanen P; Funalot B; Molinier-Frenkel V; Audard V; Hittinger L; Delbarre MA; Teiger E; Damy T
ESC Heart Fail; 2022 Apr; 9(2):1314-1327. PubMed ID: 35128833
[TBL] [Abstract][Full Text] [Related]
7. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
Hänselmann A; Berliner D; Bauersachs J; Bavendiek U
Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775
[TBL] [Abstract][Full Text] [Related]
8. Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival.
Kharoubi M; Bodez D; Bézard M; Zaroui A; Galat A; Guendouz S; Gendre T; Hittinger L; Attias D; Mohty D; Bergoend E; Itti E; Lebras F; Hamon D; Poullot E; Molinier-Frenkel V; Lellouche N; Deux JF; Funalot B; Fannen P; Oghina S; Arrouasse R; Lecorvoisier P; Souvannanorath S; Amiot A; Teiger E; Bougouin W; Damy T
Amyloid; 2022 Jun; 29(2):79-91. PubMed ID: 35114877
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac amyloidosis: State of art in 2022].
Oghina S; Delbarre MA; Poullot E; Belhadj K; Fanen P; Damy T
Rev Med Interne; 2022 Sep; 43(9):537-544. PubMed ID: 35870985
[TBL] [Abstract][Full Text] [Related]
10. When and how do patients with cardiac amyloidosis die?
Escher F; Senoner M; Doerler J; Zaruba MM; Messner M; Mussner-Seeber C; Ebert M; Ensinger C; Mair A; Kroiss A; Ulmer H; Schneiderbauer-Porod S; Ebner C; Poelzl G
Clin Res Cardiol; 2020 Jan; 109(1):78-88. PubMed ID: 31134330
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
13. Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France.
Damy T; Zaroui A; de Tournemire M; Kharoubi M; Gounot R; Galat A; Guendouz S; Funalot B; Itti E; Roulin L; Audard V; Fanen P; Leroy V; Poulot E; Belhadj K; Mallet S; Deep Singh Chadah G; Planté-Bordeneuve V; Gendre T; Chevalier X; Guignard S; Bequignon E; Bartier S; Folliguet T; Lemonier F; Audureau E; Tixier D; Canoui-Poitrine F; Lefaucheur JP; Souvannanorath S; Authier FJ; Maupou S; Hittinger L; Molinier-Frenkel V; David JP; Broussier A; Oghina S; Teiger E
Arch Cardiovasc Dis; 2023 Oct; 116(10):433-446. PubMed ID: 37640624
[TBL] [Abstract][Full Text] [Related]
14. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
Bézard M; Kharoubi M; Galat A; Poullot E; Guendouz S; Fanen P; Funalot B; Moktefi A; Lefaucheur JP; Abulizi M; Deux JF; Gendre T; Audard V; El Karoui K; Canoui-Poitrine F; Zaroui A; Itti E; Teiger E; Planté-Bordeneuve V; Oghina S; Damy T
Eur J Heart Fail; 2021 Feb; 23(2):264-274. PubMed ID: 33094885
[TBL] [Abstract][Full Text] [Related]
15. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.
Nakagawa M; Sekijima Y; Yazaki M; Tojo K; Yoshinaga T; Doden T; Koyama J; Yanagisawa S; Ikeda S
Amyloid; 2016; 23(1):58-63. PubMed ID: 26852880
[TBL] [Abstract][Full Text] [Related]
16. Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
Stamatelopoulos K; Delialis D; Georgiopoulos G; Tselegkidi MI; Theodorakakou F; Dialoupi I; Bambatsias D; Petropoulos I; Vergaro G; Ikonomidis I; Tzortzis S; Briasoulis A; Kanakakis J; Trougakos I; Dimopoulos MA; Kastritis E
Int J Cardiol; 2022 Sep; 363():102-110. PubMed ID: 35716935
[TBL] [Abstract][Full Text] [Related]
17. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.
Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S
Circulation; 2009 Sep; 120(13):1203-12. PubMed ID: 19752327
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
19. Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients.
Donnelly JP; Gabrovsek A; Sul L; Cotta C; Rodriguez ER; Tan CD; Hanna M
JACC CardioOncol; 2020 Mar; 2(1):127-130. PubMed ID: 34396218
[No Abstract] [Full Text] [Related]
20. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.
Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P
Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
